BRCA1 c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso

Authors

  • Abdou Azaque Zoure Pietro Annigoni Biomolecular Research Center (CERBA)/LABIOGENE, University of Ouaga1 Pr Joseph KI ZERBO, UFR/SVT, Burkina Faso; Laboratoiry of Biochemistry and Immunology, Faculty of Sciences, University of Mohammed V, Rabat, Morocco; Institute of Health Sciences Research (IRSS/CNRST)/Department of Biomedical and Public Health
  • Meriem Slaoui Equipe of research ONCOGYMA, University of Mohamed V, Faculty of Medicine and Pharmacy of Rabat
  • Hierrhum Aboubacar Bambara Service of Oncology, University Hospital Yalgado Ouédraogo
  • Alexis Yobi Sawadogo Service of Gynecology, University Hospital Yalgado Ouédraogo
  • Tegwendé Rebeca Compaoré 1Pietro Annigoni Biomolecular Research Center (CERBA)/LABIOGENE, University of Ouagal Pr Joseph KI ZERBO, UFR/SVT,
  • Nabonswindé Lamoussa Marie Ouédraogo Service of General Surgery and Digestive, University Hospital Yalgado Ouédraogo
  • Mohammed El Mzibri Biology Unit and Medical Research, CNESTEN, Rabat
  • Mohammed Attaleb Biology Unit and Medical Research, CNESTEN, Rabat
  • Si Simon Traoré Service of General Surgery and Digestive, University Hospital Yalgado Ouédraogo
  • Jacques Simpore 1Pietro Annigoni Biomolecular Research Center (CERBA)/LABIOGENE, University of Ouagal Pr Joseph KI ZERBO, UFR/SVT
  • Youssef Bakri Laboratoiry of Biochemistry and Immunology, Faculty of Sciences, University of Mohammed V, Rabat

DOI:

https://doi.org/10.4081/jphia.2018.663

Keywords:

Breast cancer, BRCA1, hereditary, Burkina Faso

Abstract

The worldwide variation of BRCA mutations is well known. The c.68_69delAG, c.181T>G, c.798_799delTT mutations in BRCA1 were observed in Moroccan, Algerian and Tunisian Breast Cancer families and were described founder mutation in Northern Africa. The 943ins10 is also recognized a founder mutation in West Africa. To our knowledge no study has been published on BRCA1/2 germline mutations and hereditary breast cancer (HBC) in population of Burkina Faso. The aim of the present study (first in Burkina Faso) was to screen for these four mutations in 15 unrelated patients with HBC. Mutation analysis was performed by Sanger sequencing of coding exon2, Exon5 and exon11A sequences of the BRCA1 gene. Blood specimens of 15 patients from Burkina Faso, with HBC were collected at the University Hospital Yalgado OUEDRAOGO( CHU-YO) of Ouagadougou in Burkina Faso. c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations were not detected in any of the 15 women diagnosed with family breast cancer history. Genetic analysis in this study, we show that targeting relevant exons in BRCA1 genes did not allow detection of mutations in the population of Burkina Faso. Therefore, such an approach may be of interest to perfom a complete sequencing of BRCA1 and BRCA2 genes in families at a high risk of developing breast cancer in Burkina Faso.

Download data is not yet available.

Downloads

Published

06-07-2018

How to Cite

Zoure, A. A., Slaoui, M., Bambara, H. A., Sawadogo, A. Y., Compaoré, T. R., Ouédraogo, N. L. M., El Mzibri, M., Attaleb, M., Traoré, S. S., Simpore, J., & Bakri, Y. (2018). BRCA1 c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso. Journal of Public Health in Africa, 9(1). https://doi.org/10.4081/jphia.2018.663

Issue

Section

Original Articles

Similar Articles

You may also start an advanced similarity search for this article.